SEARCH
Endocare
Irvine, CA 92618 USA
Phone
Fax
Research Sector Medical Devices & Tech
Summary Description Minimally Invasive Technology for Tissue and Tumor Ablation
Management Terrence A. Noonan, Director, Interim CEO & Interim President; Michael Rodriguez, CFO; Clint B. Davis, Senior Vice President, Legal Affairs, General Counsel and Secretary Click here for Financial Data
Keywords: cancer, urological, surgery products, urology, prostate, urinary, bladder, erectile, advamed, cryotherapy, renal, pain, management, ablation, kidney, liver, lung, cryoablation, minimally invasive, metastases, palliative intervention
Updated: Aug. 22, 2013
Description
Endocare, Inc. is developing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing cryoablation (freezing) technologies for the treatment of ......view more
Products / Services
Cryoablation is a minimally invasive means of destroying cancerous and other target tissues in a non-toxic manner without the use of open surgery, radiation or dangerous chemicals. Cryocare CS is a fu......view more
Technology / Differentiation
One key element of the FDA-cleared Cryocare CS system is the AutoFreeze, a computer-controlled automated freezing mechanism that utilizes optimal power settings based upon target endpoint temperatures...view more
Market / Customers
Endocare's cryoablation technology platforms are marketed and sold by a direct-sales force to urologists and interventional radiologists. To date, the majority of sales have been to physicians for med......view more
Status
Endocare announced that it had agreed to merge with Israel-based Galil Medical in November 2008, a move that will result in a company with approximately $55 million in TTM revenues....view more